Back to Peptide Index

5-Amino-1MQ

MetabolicEvidence Level: researchNot FDA-approved for general therapeutic use; ongoing research and clinical validation required
Peptide #38

5-Amino-1MQ is a small molecule inhibitor specifically targeting the enzyme NNMT. This enzyme plays a key role in regulating cellular metabolism, energy expenditure, and fat accumulation. By inhibiting NNMT, 5-Amino-1MQ helps optimize metabolic pathways, potentially supporting improved metabolic health, reduced fat accumulation, and enhanced physical performance.

Overview

5-Amino-1MQ is a novel small molecule compound studied extensively for its promising ability to enhance metabolic health, facilitate weight loss, and support physical performance optimization.

How It Works

5-Amino-1MQ specifically inhibits NNMT, enhancing energy expenditure, reducing fat storage, and improving overall metabolic efficiency.

Clinical Effects

Enhances metabolic health, facilitates weight loss, supports physical performance optimization, improves energy metabolism, increases energy expenditure, promotes fat reduction, enhances insulin sensitivity, improves physical endurance and recovery

Therapeutic Applications

Obesity management, metabolic health optimization, physical performance enhancement

Research Studies

Clinical Trials

Initial human studies indicate promising metabolic and physical performance improvements; comprehensive clinical validation remains ongoing

Preclinical Studies

Preclinical studies indicate significant enhancement in weight loss and reduction in fat accumulation

Frequently Asked Questions

Is 5-Amino-1MQ legally available? 5-Amino-1MQ is legally available for research purposes from specialized suppliers but is not currently FDA-approved for general therapeutic use. Have human trials been conducted with 5-Amino-1MQ? Initial human studies indicate promising metabolic and physical performance improvements. Comprehensive clinical validation remains ongoing to confirm these preliminary results. What are potential side effects of 5-Amino-1MQ? Reported side effects from early research are minimal and generally mild, including transient gastrointestinal symptoms. Ongoing safety evaluations continue to assess its long-term profile. How is 5-Amino-1MQ typically administered? 5-Amino-1MQ is typically administered orally or through subcutaneous injections in research settings, with dosing protocols tailored according to specific therapeutic objectives and clinical research protocols. Can 5-Amino-1MQ be combined with other metabolic treatments? Controlled clinical studies are required to safely evaluate the effectiveness and interactions of 5-Amino-1MQ when combined with other therapeutic interventions. Does 5-Amino-1MQ offer permanent metabolic benefits? 5-Amino-1MQ significantly enhances metabolic health and physical performance during administration. Sustained therapeutic benefits typically require ongoing or periodic treatment supported by comprehensive lifestyle management.

Quick Information

Safety Information

Safety Profile

Ongoing safety evaluations continue to assess its long-term profile

Contraindications

Side Effects: Minimal and generally mild, including transient gastrointestinal symptoms Safety Profile: Ongoing safety evaluations continue to assess its long-term profile

Side Effects

Minimal and generally mild, including transient gastrointestinal symptoms

Research References

Pissios, P. (2017). Nicotinamide N-Methyltransferase: More Than a Vitamin B3 Clearance Enzyme. Trends in Endocrinology & Metabolism. Kraus, D., et al. (2014). Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature. Hong, S., et al. (2015). Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization. Nature Medicine.

Additional Resources

View Source